The Impact of Mutant p53 in the Non-Coding RNA World

by Silvia Di Agostino
Published 2020-03-01

New therapeutic strategies to treat human cancers expressing mutant p53 proteins

by Giovanni Blandino, Silvia Di Agostino
Published 2018-02-01

New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer

by Giulia Fontemaggi, Chiara Turco, Gabriella Esposito, Silvia Di Agostino
Published 2021-06-01

Targeting mutant p53 in cancer: the latest insights

by Silvia Di Agostino, Giulia Fontemaggi, Sabrina Strano, Giovanni Blandino, Gabriella D’Orazi
Published 2019-07-01

Arenavirus as a potential etiological agent of odontogenic tumours in humans

by Marco de Feo, Cristina De Leo, Umberto Romeo, Paola Muti, Giovanni Blandino, Silvia Di Agostino
Published 2020-02-01

The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas

by Fabio Valenti, Andrea Sacconi, Federica Ganci, Giuseppe Grasso, Sabrina Strano, Giovanni Blandino, Silvia Di Agostino
Published 2019-09-01

Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development

by Silvia Di Agostino, Anna Riccioli, Paola De Cesaris, Giulia Fontemaggi, Giovanni Blandino, Antonio Filippini, Francesco Fazi, Francesco Fazi
Published 2020-05-01

Loss of Two-Pore Channel 2 (TPC2) Expression Increases the Metastatic Traits of Melanoma Cells by a Mechanism Involving the Hippo Signalling Pathway and Store-Operated Calcium Entr...

by Antonella D’Amore, Ali Ahmed Hanbashi, Silvia Di Agostino, Fioretta Palombi, Andrea Sacconi, Aniruddha Voruganti, Marilena Taggi, Rita Canipari, Giovanni Blandino, John Parrington, Antonio Filippini
Published 2020-08-01

The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma

by Valentina Panzeri, Isabella Manni, Alessia Capone, Chiara Naro, Andrea Sacconi, Silvia Di Agostino, Luisa deLatouliere, Andrea Montori, Emanuela Pilozzi, Giulia Piaggio, Gabriele Capurso, Claudio Sette
Published 2021-02-01

CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells

by Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini, Anna Riccioli
Published 2021-08-01